A compound in green tea -- epigallocatechin gallate -- may help combat cancer by shrinking tumors, researchers in Scotland suggest. Study leader Dr. Christine Dufes of the Strathclyde Institute of Pharmacy and Biomedical Sciences and colleagues at the University of Glasgow said the team used an approach that allowed the treatment of epigallocatechin gallate delivered specifically to the tumors intravenously. The study, published in the journal Nanomedicine, found nearly two-thirds of the tumors it was delivered to either shrank or disappeared within one month. In addition, the treatment displayed no side effects to normal tissues, Dufes said. For example, on two different types of skin cancer, 40 percent of both types of tumor vanished, while 30 percent of one and 20 percent of another shrank, while a further 10 percent of one stabilized, Dufes said. "These are very encouraging results which we hope could pave the way for new and effective cancer treatments. When we used our method, the green tea extract reduced the size of many of the tumors every day, in some cases removing them altogether. By contrast, the extract had no effect at all when it was delivered by other means, as every one of these tumors continued to grow," Dufes said in a statement. "This research could open doors to new treatments for what is still one of the biggest killer diseases in many countries."
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor